Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

The purpose of the study is to determine the safety and efficacy of 5.0% AN2690 Solution in the treatment of distal, subungual onychomycosis of the great target toenail.

 

Condition Intervention Phase
Onychomycosis Drug: AN2690 Solution, 5.0% Phase 2

 
Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open-Label, Rising Multiple-Dose, Multi-Center Study to Evaluate the Safety and Efficacy of Topically Applied AN2690 5.0% and 7.5% Solution for the Treatment of Adult Subjects With Onychomycosis of the Great Toenail

Date of article/Start date of trial: 14 January 2011

Trial Phase: Phase 2

clinical Trials Gov ID: NCT01278394

Trial status: Completed

Back to New Antifungals